Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Current Leases (2020 - 2024)

Updated

Alterity Therapeutics (ATHE) recorded Current Leases of -$137,235 in the quarter ended Jun 30, 2026, compared with $56,707 a year earlier.

Analysis

Alterity Therapeutics (ATHE) Current Leases (2020 - 2024) Analysis & Trends

Starting with the quarter ended Jun 30, 2020, Alterity Therapeutics' Current Leases history includes 9 quarters.

  • Across earlier years, Current Leases came in at $56,707 in the year ended Jun 30, 2025, $519.14 in the year ended Jun 30, 2024 (-49.7%), $1,032 in the year ended Jun 30, 2023 (-97.6%) and $42,874 in the year ended Jun 30, 2022 (+46.9%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Current Leases in data going back to the quarter ended Jun 30, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Alterity Therapeutics 41.90 Mn -41.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 39,007.48
Jun 30, 2024 71,248.53
Jun 30, 2021 58,354.37
Jun 30, 2020 53,370.67
API Access

Alterity Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ATHE&period=max&api_key=YOUR_API_KEY